Attention Deficit Hyperactivity Disorder
Conditions
Keywords
Psychotherapy, group, Adults
Brief summary
This pilot study aims to assess patient satisfaction and preliminary efficacy of a psychoeducational group treatment, using a randomized waitlist-controlled trial, at two different outpatient clinics in mid-Norway. All participants will receive standard treatment during the intervention period. Assessment of client satisfaction (CSQ 8), general self-efficacy (GSE-6), ADHD-related quality of life (AAQoL) symptoms of ADHD (SCL-9; ASRS), and work participation will be conducted at time of recruitment prior to randomization (T0), pre- (T1), post-treatment (T2), with a 10 week follow-up.
Interventions
BEHAVIORALPsychoeducational group therapy
The group-based psychoeducational program consists of 10 sessions, run over 10 consecutive weeks. Each session consist of a lecture, given by a recruited expert on the topic of the session (20 minutes) with a following discussion of the topic (45 minutes), facilitated by the course leader. All sessions are organized and led by the course leader, which also includes keeping structure in time, discussion and closing of the session. Psychoeducation comes in addition to standard treatment (ADHD treatment as usual).
BEHAVIORALWaiting list
Waiting list and standard treatment (ADHD treatment as usual)
OTHERStandard treatment
Standard treatment consists of diagnostic assessment of ADHD and comorbidity, as well as treatment with medication. In addition, some patients receive cognitive behavioral therapy, although this is not systematically given to every patient. If needed, patients are also offered assistance with regard to economy, housing, education and work. As well as contact with family and network.
Sponsors
Helse Nord-Trøndelag HF
Norwegian University of Science and Technology
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
a Norwegian multicenter study
Eligibility
Sex/Gender
ALL
Age
18 Years to 67 Years
Healthy volunteers
No
Inclusion criteria
* confirmed ADHD diagnosis * speaking a Scandinavian language
Exclusion criteria
* not able or willing to give informed consent * psychosis * severe learning difficulties
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in patient satisfaction | Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks) | Measured with a modified version of the Client Satisfaction Questionnaire (CSQ-8). The scale consists of 8 items measured on a scale from 1 to 4. A sum score between 8 and 32 indicate the level of satisfaction with services provided. |
| Change in general self-efficacy | Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks) | Measured with General Self-Efficacy Scale (GSE-6), a short-form measure of self-efficacy. Self-efficacy is regarded as a protective factor in adapting to stress and chronic illness. The scale consists of 6 items, measured on a 4-point scale, with a possible range of 6-24. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in ADHD-related symptoms (ASRS) | Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks) | Measured with ASRS, a self-reporting scale for ADHD-related symptoms in adults. The scale consists of 18 items, based on DSM-V diagnostic criteria for ADHD. The items are measured on a 5-point scale, with a possible range of 0-72. |
| Change in ADHD-related symptoms (SCL-9) | Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks) | Measured with 9 items from the SCL-90. SCL-9 is an ADHD-specific scale, consisting of 9 items of the original 90. SCL-9 covers the specific characteristic traits of ADHD. |
| Change in ADHD-related quality of life | Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks) | Measured with AAQoL - which covers ADHD-specific quality of life and function. AAQoL consists of 29 questions measuring health related quality of life among adults with ADHD. |
Countries
Norway
Outcome results
None listed